Tag
Dipna Pharmachem Limited
5 articles
Dipna Pharmachem Limited reported a substantial increase in net profit for fiscal year 2026, reaching ₹263.19 lakhs compared to ₹97.40 lakhs the previous year, driven by its steel segment which generated ₹7,089.14 lakhs in revenue. The company bolstered its financial position through a preferential issue and convertible warrants, totaling ₹2,113.00 lakhs, primarily intended for working capital. However, recent departures of two independent directors, Nandish Jani and Parin Bhavsar, citing personal reasons and pre-occupancy respectively, introduce a degree of corporate governance uncertainty that investors should monitor. The rescheduled board meeting to review financial results suggests ongoing scrutiny of the company’s performance.
Dipna Pharmachem FY26 Audited Results and Financial Disclosures
Dipna Pharmachem reported audited FY26 net profit of ₹263.19 lakhs, a significant increase from ₹97.40 lakhs in FY25.
The company raised ₹219.63 lakhs through a preferential issue of equity shares and
Dipna Pharmachem FY2026 Net Profit ₹263.19 Lakhs
Board approved audited financial results for Q4 and FY ended March 31, 2026, reporting a net profit of ₹263.19 lakhs for the full year.
Company operates in two reportable segments: Chemicals (revenue
Dipna Pharmachem Independent Director Resigns
Mr. Nandish Shaileshbhai Jani resigned as Non-Executive and Independent Director effective June 10, 2026 due to personal reasons.
The resignation disclosure is made pursuant to SEBI Listing Regulation
Dipna Pharmachem Independent Director Parin Bhavsar Resigns
Mr. Parin Bhavsar resigned as Non-Executive and Independent Director of Dipna Pharmachem effective 12th May 2026.
The stated reason for resignation was pre-occupancy, with no other material reasons di
Dipna Pharmachem Reschedules Board Meeting to July 2
Dipna Pharmachem rescheduled its board meeting from July 1 to July 2, 2026 to discuss financial results.
The meeting will consider audited financial results for half year and year ended March 31, 2026